Investigators evaluated the risk for hepatocellular carcinoma after direct-acting antivirals (DAA)-cured hepatitis C virus (HCV) in DAA-naive adults with HIV-HCV coinfection and advanced fibrosis.

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

Olezarsen receives FDA Breakthrough Therapy status for adults with severe hypertriglyceridemia following positive results from CORE and CORE2 trials.

The FDA approved perioperative durvalumab with FLOT chemotherapy for eligible patients with resectable Stage II-IVA gastric and GEJ cancers.

The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.

A manufacturing issue with Abbott FreeStyle Libre 3 sensors led to inaccurate readings, affecting about 3 million sensors worldwide.

Women with prepregnancy obesity are more likely to have children with neurodevelopmental disabilities, specifically showing greater risks for epilepsy and intellectual disability. Women with ...

Intravenous anesthesia for painless gastroscopy among older adults is associated with lower postoperative cognitive dysfunction.

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

The World Health Organization's new strategic initiative focused on how to harness digital health technologies to improve health.

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

Credit: Getty Images The WHO released a guideline on the use of GLP-1 therapies for the treatment of obesity among adults. The World Health Organization (WHO) has released an evidence-informed ...